Basics RAPT Therapeutics, Inc. IPO Date: October 28, 2019 Sector: Healthcare Industry: Biotech Market Cap: $955.06M Activated in VL: True Average Daily Range Avg Daily Range: $0.72 | 4.01% Avg Daily Range (30 D): $0.80 | 2.67% Avg Daily Range (90 D): $0.90 | 4.15% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .39M Avg Daily Volume (90 D): .31M Trade Size Avg Trade Size (Sh.): 95 Avg Trade Size (Sh.) (30 D): 66 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 1,145 Avg Inst. Trade: $1.63M Avg Inst. Trade (30 D): $1.25M Avg Inst. Trade (90 D): $1.62M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.58M Avg Closing Trade (30 D): $1.09M Avg Closing Trade (90 D): $1.41M Avg Closing Volume: 12.63K     News Nov 10, 2025 @ 6:00 PM Food Allergy Market Valued at USD 3 Billion across... Source: Delveinsight Oct 22, 2025 @ 3:12 AM RAPT Therapeutics Announces Pricing of Public Offe... Source: Rapt Therapeutics, Inc. Oct 19, 2025 @ 12:00 PM RAPT Therapeutics to Report Topline Data from Phas... Source: Rapt Therapeutics, Inc. Sep 29, 2025 @ 9:00 AM RAPT Therapeutics Announces FDA Clearance of IND A... Source: Rapt Therapeutics, Inc. Jun 23, 2025 @ 12:00 PM RAPT Therapeutics Names Two Industry Veterans to i... Source: Rapt Therapeutics, Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $10.67 $-.65 $-.65 Diluted EPS $10.67 $-.65 $-.65 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -105.64M $ -17.58M $ -17.64M Operating Income / Loss $ -112.64M $ -19.37M $ -19.54M Cost of Revenue $ $ $ Net Cash Flow $ .03M $ -3.96M $ -127.85M PE Ratio 3.23     Splits Jun 17, 2025:   1:8